Cardiac care reputation and capabilities can be enhanced through the integration of key genetic tests and genomic medicine services that can be practically integrated into patient care. Genetic tests and services around cardiology include:

• Familial Hypercholesterolemia
• Warfarin Response
• Long QT Syndrome
• Hypertrophic Cardiomyopathy (HCM)
• Genetic testing for Atrial Fibrillation
• KIF6 Test
• CYP2C19 and Plavix
• Family History Risk Assessment (streamlines cardiologists and genetic counselor workload, increasing capacity)
• Web based decision support
• National Call Center of Genetic Experts (co-branded access, if required)

GOAL: Improve diagnosis, create repeat business and drive more patients to access cardiac care services

This program enables cardiologists to improve care and services to patients. Hypertrophic Cardiomyopathy is an example of a disease area that has received a lot of press given the dramatic and sudden impact it can have on athletes and seemingly "healthy" people. HCM is not an uncommon heart disease — its exact frequency is unknown, however recent data indicates that 1 in 500 people are affected in all populations. Along with helping to confirm diagnosis, a key benefit of integrating the HCM test into cardiologists' workflow is to identify asymptomatic family members. Implementing genomic medicine enables cardiology to address these issues early — for the whole family — to ensure appropriate treatment and monitoring from childhood to adulthood. Introducing these types of innovations keeps families loyal to the hospital and the community knowledgeable.